VitalStone Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$60K Buy
528
+3
+0.6% +$356 0.04% 163
2024
Q2
$65K Buy
525
+3
+0.6% +$386 0.05% 156
2024
Q1
$69K Hold
522
0.05% 156
2023
Q4
$57K Hold
522
0.05% 147
2023
Q3
$53K Hold
522
0.04% 126
2023
Q2
$56K Buy
+522
New +$59.3K 0.03% 321
2023
Q1
Sell
-567
Closed -$63K 452
2022
Q4
$63K Buy
+567
New +$58K 0.04% 135

Other funds holding MRK

VitalStone Financial's MRK Position: Q3 2024 in Review

VitalStone Financial increased its Merck (MRK) stake by 0.57% in Q3 2024, buying an estimated $356 and bringing the position to 528 shares worth $60K. The position accounts for 0.04% of the portfolio, ranked #163.

VitalStone Financial first reported a position in MRK in Q4 2022 and has held it in 7 quarters since. The position peaked at $69K in Q1 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • VitalStone Financial held 528 shares of Merck worth $60K as of Q3 2024.
  • VitalStone Financial bought 3 Merck shares in Q3 2024, an estimated $356.
  • Merck made up 0.04% of VitalStone Financial's portfolio in Q3 2024, its #163 holding.
  • VitalStone Financial first reported a position in Merck in Q4 2022 and has held it in 7 quarters since.
  • VitalStone Financial's Merck position peaked at $69K in Q1 2024.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.